Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D05FQX
|
|||
| Drug Name |
N-alkyl-4-oxazolecar boxamide derivative 1
|
|||
| Synonyms |
PMID26413912-Compound-92
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
ALLERGAN, INC. WOODWARD, David F. MARTOS, Jose L. CARLING, William R. POLOSO, Neil J. WANG, Jenny W
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C29H39N3O6
|
|||
| Canonical SMILES |
COC1=CC(=C(C=C1)CCC(=O)O)C(=O)N2CCCC2C3=NC(=CO3)C(=O)NCCCCC4CCCCC4
|
|||
| InChI |
1S/C29H39N3O6/c1-37-22-14-12-21(13-15-26(33)34)23(18-22)29(36)32-17-7-11-25(32)28-31-24(19-38-28)27(35)30-16-6-5-10-20-8-3-2-4-9-20/h12,14,18-20,25H,2-11,13,15-17H2,1H3,(H,30,35)(H,33,34)/t25-/m0/s1
|
|||
| InChIKey |
CQXXOQIYQSPKKU-VWLOTQADSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Fatty acid amide hydrolase (FAAH) | Target Info | Inhibitor | [1] |
| Target's Patent Info | Fatty acid amide hydrolase (FAAH) | Target's Patent Info | [1] | |
| BioCyc | Anandamide degradation | |||
| KEGG Pathway | Retrograde endocannabinoid signaling | |||
| Panther Pathway | Anandamide degradation | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Fatty acid amide hydrolase inhibitors: a patent review (2009-2014).Expert Opin Ther Pat. 2015;25(11):1247-66. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.